1887

Abstract

Murine monoclonal antibodies (MAbs) gp41-1 (IgG2a) and gp41-2 (IgG1), directed against the envelope glycoprotein of human immunodeficiency virus type 1 (HIV-1), were produced and characterized. These MAbs recognized both gp160 and gp41 and reacted with divergent HIV-1 isolates. Surface binding assays using viable HIV-infected cells indicated that these MAbs were directed against surface-exposed epitopes. Both MAbs caused a reduction in reverse transcriptase activity. Syngeneic monoclonal anti-idiotypic antibodies (anti-ids) against gp41-1 were also generated. Six anti-ids (agp41-11 to agp41-16) were selected by ELISA using F(ab′) fragments of gp41-1; no reaction was observed when fragments from an irrelevant IgG2a MAb were used. Anti-ids were recognized by both gp41-1 and gp41-2 biotinylated MAbs. Competitive ELISA studies suggested that anti-ids were directed against at least three distinct idiotopes on gp41-1. All anti-ids reacted with idiotopes associated with both heavy and light chains and not with separated chains. The binding of MAbs gp41-1 and gp41-2 to HIV-infected cells was inhibited by each anti-id, except for the binding of gp41-2 which was not affected by the presence of agp41-12. Immunization of rabbits with agp41-11 and agp41-13 resulted in an antibody response against recombinant gp160. These studies indicated that these two anti-ids contain a surrogate image of the antigen recognized by gp41-1.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-72-1-51
1991-01-01
2021-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jgv/72/1/JV0720010051.html?itemId=/content/journal/jgv/10.1099/0022-1317-72-1-51&mimeType=html&fmt=ahah

References

  1. Amit A. G., Mariuzza R. A., Phillips S. E. V., Poljak R. J. 1986; Three dimensional structure of an antigen-antibody complex at 2.8 Å resolution. Science 233:747–753
    [Google Scholar]
  2. Arthur L. O., Pyle S. W., NaRa P. L., Bess J. W. Jr, Gonda M. A., Kelliher J. C., GildeN R. V., Robey W. G., Bolognesi D. P., Gallo R. C., Fischinger P. J. 1987; Serological responses in chimpanzees inoculated with human immunodeficiency virus glycoprotein (gp120) subunit vaccine. Proceedings of the National Academy of Sciences, U.S.A. 84:8583–8587
    [Google Scholar]
  3. Barré-Sinoussi F., Chermann J. C., Rey F., Nugeyre M. T., Chamaret S., Gruest J., Dauguet C., Axler-Blin C., Vezinet-Brun F., Rouzioux C., Rozenbaum W., Montagnier L. 1983; Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868–871
    [Google Scholar]
  4. Beretta A., Grassi F., Pelagi M., Clivio A., Parravicini C., Giovinazzo G., Andronico F., Lopalco F., Verani P., Butto S., Titti F., Rossi G. B., Viale G., Ginelli E., Siccardi A. G. 1987; HIV env glycoprotein shares a cross-reactive epitope with a surface protein present on activated human monocytes and involved in antigen presentation. European Journal of Immunology 17:1793–1798
    [Google Scholar]
  5. Berman P. W., Groopman J. E., Gregory T., Clapham P. R., Weiss R. A., Ferriani R., Riddle L., Shimasaki C., Lucas C., Lasky L. A., Eichberg J. W. 1988; Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gpl20. Proceedings of the National Academy of Sciences, U.S.A. 85:5200–5204
    [Google Scholar]
  6. Bona C. A., Heber-Katz E., Paul W. E. 1981; Idiotype-anti-idiotype regulation. Journal of Experimental Medicine 153:951–967
    [Google Scholar]
  7. Brodeur B. R., Tsang P. S. 1986; High yield monoclonal antibody production in ascites. Journal of Immunological Methods 86:239–241
    [Google Scholar]
  8. Brodeur B. R., Larose Y., Tsang P., Hamel J., Ashton F., Ryan A. 1985; Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody. Infection and Immunity 50:510–516
    [Google Scholar]
  9. Cazenave P. A. 1977; Idiotypic-anti-idiotypic regulation of antibody synthesis in rabbits. Proceedings of the National Academy of Sciences, U.S.A 74:5122–5125
    [Google Scholar]
  10. Chanh T. C., Dreesman G. R., Kanda P., Linette G. P., Sparrow J. T., Ho D. D., Kennedy R. C. 1986; Induction of anti-HIV neutralizing antibodies by synthetic peptides. EMBO Journal 5:3065–3071
    [Google Scholar]
  11. Chanh T. C., Kennedy R. C., Kanda P. 1988; Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response. Cellular Immunology 111:77–86
    [Google Scholar]
  12. Chirmule N., Kalyanaraman V., Oyaizu N., Pahwa S. 1988; Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses. Journal of Acquired Immune Deficiency Syndrome 1:425–430
    [Google Scholar]
  13. Dalgleish A. G., Chanh T. C., Kennedy R. C., Kanda P., Clapham P. R., Weiss R. A. 1988; Neutralization of diverse HIV-1 strains by monoclonal antibodies raised against a gp41 synthetic peptide. Virology 165:209–215
    [Google Scholar]
  14. Diamond D. C., Sleckman B. P., Gregory T., Lasky L. A., Greenstein J. L., Burakoff S. J. 1988; Inhibition of CD4+ T cell function by the envelope protein, gpl20. Journal of Immunology 141:3715–3717
    [Google Scholar]
  15. Di Marzo Veronese F., de Vico A. L., Copeland T. D., Oroszlan S., Gallo R. C., Sarngadharan M. G. 1985; Characterization of gp41 as the transmembrane protein encoded by the HTLV-III/LAV envelope gene. Science 229:1402–1405
    [Google Scholar]
  16. Dupuis G., Bastin B. 1985; Binding of phytohemagglutinin to porcine lymphocyte receptors. Time-course studies and comparative binding isotherms using whole cells or cellular receptors incorporated into phospholipid vesicles. Canadian Journal of Biochemistry and Cell Biology 63:1033–1043
    [Google Scholar]
  17. Evans L. A., Thomson-Honnebier G., Steimer K., Paoletti E., PERKUS M. E., HOLLANDER H., LEVY J. A. 1989; Antibody-dependent cellular cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV. AIDS 3:273–276
    [Google Scholar]
  18. Faucher S., Cardin J., Talbot B., Dupuis G. 1989; Properties of three monoclonal antibodies that recognize an 80-KDa phytohemagglutinin-binding glycoprotein from porcine lymphocytes. Canadian Journal of Biochemistry and Cell Biology 67:224–232
    [Google Scholar]
  19. Gnann J. W. Jr, Schwimmbeck P. L., Nelson J. A., Truax A. B., Oldstone M. B. A. 1987a; Diagnosis of AIDS by using a 12-amino acid peptide representing an immunodominant epitope of the human immunodeficiency virus. Journal of Infectious Diseases 156:261–267
    [Google Scholar]
  20. Gnann J. W. Jr, Nelson J. A., Oldstone M. B. A. 1987b; Fine mapping of an immunodominant domain in the transmembrane glycoprotein of human immunodeficiency virus. Journal of Virology 61:2639–2641
    [Google Scholar]
  21. Golding H., Shearer G. M., Hillman K., Lucas P., Man-Ischewitz J., Zajac R. A., Clerici M., Gress R. E., Boswell R. N., Golding B. 1989; Common epitope in human immunodeficiency virus (HIV) I-gp41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals. Journal of Clinical Investigation 83:1430–1435
    [Google Scholar]
  22. Hamel J., Brodeur B. R. 1990; Induction of an immune response to the porin of Haemophilus influenzae type b by monoclonal antiidiotypic antibodies. Microbial Pathogenesis8 (in press)
    [Google Scholar]
  23. Hamel J., Brodeur B. R., Larose Y., Tsang P. S., Belmaaza A., Montplaisir S. 1987; A monoclonal antibody directed against a serotype-specific, outer-membrane protein of Haemophilus influenzae type B. Journal of Medical Microbiology 23:163–170
    [Google Scholar]
  24. Haseltine W. A., Terwilliger E. F., Rosen C. A., Sodroski J. G. 1990; Structure and function of human pathogenic retroviruses. In Retrovirus Biology and Human Disease pp. 241–283 Edited by Gallo R. C., Wong-Staal F. New York: Marcel Dekker;
    [Google Scholar]
  25. Hiernaux J. R. 1988; Idiotypic vaccines and infectious diseases. Infection and Immunity 56:1407–1413
    [Google Scholar]
  26. Hiernaux J., Bona C. A., Baker P. J. 1981; Neonatal treatment with low doses of anti-idiotypic antibody leads to the expression of a silent clone. Journal of Experimental Medicine 153:1004–1008
    [Google Scholar]
  27. Hu S. L., Fultz P. N., McClure H. M., Eichberg J. W., Thomas E. K., Zarling J., Singhal M. C., Kosowski S. G., Swenson R. B., Anderson D. C., Todaro G. 1987; Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees. Nature, London 328:721–723
    [Google Scholar]
  28. Jerne N. K. 1974; Towards a network theory of the immune response. Annals of Immunology (Paris) 125C:373–389
    [Google Scholar]
  29. Jerne N. K. 1984; Idiotypic networks and other preconceived ideas. Immunological Review 79:5–24
    [Google Scholar]
  30. Kennedy R. C., Henkel R. D., Dreesman G. R. 1986a; Further characterization of internal image-bearing anti-idiotypic antibodies: specific binding to immunoglobulin receptors on murine hybridoma cells secreting antibodies to hepatitis B surface antigen. Scandinavian Journal of Immunology 23:481–489
    [Google Scholar]
  31. Kennedy R. C., Henkel R. D., Pauletti D., Allan J. S., Lee T. H., Essex M., Dreesman G. R. 1986b; Antiserum to a synthetic peptide recognizes the HTLV-III envelope glycoprotein. Science 231:1556–1559
    [Google Scholar]
  32. Kowalski M., Potz J., Basiripour L., Dorfman T., Goh W. C., Terwilliger E., Dayton A., Rosen C., Haseltine W., Sodroski J. 1987; Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351–1355
    [Google Scholar]
  33. Krust B., Laurent A. G., Montagnier L., Hovanessian A. G. 1987; A sensitive dot immunobinding assay for the detection of antibodies specific for HIV. Annales de l’Institut Pasteur/Virology 138:245–252
    [Google Scholar]
  34. Lifson J. D., Feinberg M. B., Reyes G. R., Rabin L., Banapour B., Chakrabarti S., Moss B., Wong-Staal F., Steimer K. S., Engleman E. G. 1986; Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. Nature, London 323:725–728
    [Google Scholar]
  35. Lussier M., Brodeur B. R., Winston S. 1989; Detection of Neisseria gonorrhoeae by dot-enzyme immunoassay using monoclonal antibodies. Journal of Immunoassay 10:373–394
    [Google Scholar]
  36. McDougal J. S., Kennedy M. S., Sligh J. M., Cort S. P., Mawle A., Nicholson J. K. A. 1986; Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule. Science 231:382–385
    [Google Scholar]
  37. Myers G., Rabson A. B., Josephs S. F., Smith T. F., Berzofsky J. A., Wong-Staal F. (editors) 1989; Compilation and analysis of nucleic acid and amino acid sequences. In Human Retroviruses and AIDS 1989 pp III-61–III-67 New Mexico: Los Alamos National Laboratory;
    [Google Scholar]
  38. Neumann P. W., Benning B. J., Robinson D. G., Gilmore N., O’Shaughnessy M. V. 1986; HTLV-III infection in Canada in 1985. Canadian Medical Association Journal 135:477–480
    [Google Scholar]
  39. Nisonoff A., LaMOYi E. 1981; Implication of the presence of an internal image of the antigen in anti-idiotypic antibodies: possible application to vaccine production. Clinical Immunology 21:397–406
    [Google Scholar]
  40. Osterhaus A. D. M. E., Bunschoten E. J., Weijer K., UytdeHaag F. G. C. M. 1988; Modulation of the immune system towards antiviral immune response using anti-idiotypic structures. In Biological Applications of Anti-Idiotypes vol. II pp. 13–30 Edited by Bona C. A. Boca Raton: CRC Press;
    [Google Scholar]
  41. Parham P. 1983; On the fragmentation of monoclonal IgGl, IgG2a, and IgG2b from BALB/c mice. Journal of Immunology 131:2895–2902
    [Google Scholar]
  42. Resnick L., Di Marzo Veronese F., Schuppbach J., Tourtel-Lotte W. W., Ho D. D., Muller F., Shapshak P., Vogt M., Groopman J. E., Markham P. D., Gallo R. C. 1985; Intrablood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. New England Journal of Medicine 313:1498–1504
    [Google Scholar]
  43. Robert-Guroff M., Brown M., Gallo R. C. 1985; HTLV-III-neutralizing antibodies in patients with AIDS and AIDS-related complex. Nature, London 316:72–74
    [Google Scholar]
  44. Robey W. G., Safai B., Oroszlan S., Arthur L. O., Gonda M. A., Gallo R. C., Fischinger P. J. 1985; Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. Science 222:593–595
    [Google Scholar]
  45. Sandstrom E. G., Schooley R. T., Ho D. D., Byington R., Sarngadharan M. G., MacLane M. E., Essex M., Gallo R. C., Hirsch M. S. 1985; Detection of human anti-HTLV-III antibodies by indirect immunofluorescence using fixed cells. Transfusion 25:308–312
    [Google Scholar]
  46. Sodroski J., Goh W. C., Rosen C., Campbell K., Haseltine W. A. 1986; Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature, London 322:470–474
    [Google Scholar]
  47. Starcich B. R., Hahn B. H., Shaw G. M., McNeely P. D., Modrow S., Wolf H., Parks E. S., Parks W. P., Josephs S. F., Gallo R. C., Wong-Staal F. 1986; Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 45:637–648
    [Google Scholar]
  48. Stein B. S., Gowda S. D., Lifson J. D., Penhallow R. C., Bensch K. G., Engleman E. G. 1987; pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell 49:659–668
    [Google Scholar]
  49. Towbin H., Staehelin T., Gordon J. 1979; Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences, U.S.A. 76:4350–4354
    [Google Scholar]
  50. Urbain J., Wikler M., Franssen J. D., Collignon C. 1977; Idiotypic regulation of the immune system by the induction of antibodies against anti-idiotypic antibodies. Proceedings of the National Academy of Sciences, U.S.A 74:5126–5130
    [Google Scholar]
  51. Weigent D. A., Hoeprich P. D., Bost K. L., Brunck T. K., Reiher W. E. III, Blalock J. E. 1986; The HTLV-III envelope protein contains a hexapeptide homologous to a region of interleukin-2 receptor. Biochemical and Biophysical Research Communications 139:367–374
    [Google Scholar]
  52. Weinhold K. J., Lyerly H. K., Stanley S. D., Austin A. A., Matthews T. J., Bolognesi D. P. 1989; HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. Journal of Immunology 142:3091–3097
    [Google Scholar]
  53. Zarling J. M., Eichberg J. W., Moran P. A., McClure J., Sridhar P., Hu S. L. 1987; Proliferative and cytotoxic T cells to AIDS virus glycoproteins in chimpanzees immunized with a recombinant vaccinia virus expressing AIDS virus envelope glycoproteins. Journal of Immunology 139:988–990
    [Google Scholar]
  54. Zhou E.-M., Chanh T. C., Dreesman G. R., Kanda P., Kennedy R. C. 1987; Immune response to human immunodeficiency virus. In vivo administration of anti-idiotype induces an anti-gp160 response specific for a synthetic peptide. Journal of Immunology 139:2950–2956
    [Google Scholar]
  55. Zhou E.-M., Lohman K. L., Kennedy R. C. 1990; Administration of nonintemal image monoclonal anti-idiotypic antibodies induces idiotype-restricted responses specific for human immunodeficiency virus envelope glycoprotein epitopes. Virology 174:9–17
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-72-1-51
Loading
/content/journal/jgv/10.1099/0022-1317-72-1-51
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error